Description
XYS1 simultaneously modulates gut microbiota (enriching Bacillota, reducing Bacteroidota) and brain complement pathways, but whether microbiota changes drive brain effects or vice versa remains unclear. This mechanistic gap is critical for understanding gut-brain axis therapeutic targets.
Gap type: unexplained_observation Source paper: Panacis Quinquefolii Radix Polysaccharides Alleviate Depressive-Like Behaviors in Chronic Unpredictable Mild Stress-Induced Mice by Suppressing Complement C1Q/C3-Mediated Microglial Synaptic Pruning and Modulating Gut Microbiota. (2026, CNS neuroscience & therapeutics, PMID:41914021)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:49.557259+00:00”, “resolution_summary”: “Resolved by hypothesis h-af0ec8d843: Complement C1q-Mediated Synaptic Pruning Drives Early Cognitive Decline in Alzheimer’s Disease. Supporting evidence includes debate sess_SDA-2026-04-07-gap-pubmed-20260406-041445-ce0abc1e_task_73907230.”, “match_counts”: {“hypothesis_matches”: 1, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-af0ec8d843”, “title”: “Complement C1q-Mediated Synaptic Pruning Drives Early Cognitive Decline in Alzheimer’s Disease”, “score”: 0.304, “reason”: “11 token overlaps; entity overlap: c1q”, “analysis_id”: “legacy-pre-pipeline-import-v1”, “target_gene”: “C1Q”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.769, “confidence_score”: 0.82, “status”: “proposed”, “pubmed_evidence_ids”: [“27488256”, “28135843”, “30415925”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-041445-ce0abc1e_task_73907230”, “title”: “The abstract states that AQP4 ‘is part of the pathogenesis’ of CNS disorders and shows ‘notable variability’ in these conditions, but the precise causal mechanisms linking AQP4 alterations to disease development remain unexplained. Understanding these mechanisms is critical for developing AQP4-targeted therapeutics.\n\nGap type: unexplained_observation\nSource paper: Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders. (2023, Neurobiol Dis, PMID:36796590)”, “score”: 0.482, “reason”: “11 token overlaps; entity overlap: cns, pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041445-ce0abc1e”, “quality_score”: 0.757, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062122-bfac06c8”, “title”: “The authors identify SPI1 as a potential transcription factor regulating the hub genes but provide no mechanistic details of this regulatory relationship. Given SPI1’s role in microglial activation and neuroinflammation, this regulatory circuit may be relevant to cerebrovascular disease and neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: An integrative analysis of single-cell and bulk transcriptome and bidirectional mendelian randomization analysis identified C1Q as a novel stimulated risk gene for Atherosclerosis. (2023, Front Immunol, PMID:38179058)”, “score”: 0.46, “reason”: “10 token overlaps; entity overlap: c1q, pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062122-bfac06c8”, “quality_score”: 0.93, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062122-b65f8ebc_task_73907230”, “title”: “While the study establishes C1QA and C1QC as diagnostic biomarkers and confirms their association with atherosclerosis risk, the mechanistic pathways linking complement activation to plaque pathogenesis remain unexplained. Understanding these mechanisms is critical since atherosclerosis is a major cause of vascular dementia and stroke-related neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: An integrative analysis of single-cell and bulk transcriptome and bidirectional mendelian randomization analysis identified C1Q as a novel stimulated risk gene for Atherosclerosis. (2023, Front Immunol, PMID:38179058)”, “score”: 0.444, “reason”: “10 token overlaps; entity overlap: c1q, pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062122-b65f8ebc”, “quality_score”: 0.706, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062128-afe67892_task_9aae8fc5”, “title”: “While the study demonstrates both NF-κB pathway activation and increased C1qa expression after prolonged anesthesia, the mechanistic link between neuroinflammation and complement activation remains unclear. This connection is critical for developing targeted interventions.\n\nGap type: unexplained_observation\nSource paper: Prolonged anesthesia induces neuroinflammation and complement-mediated microglial synaptic elimination involved in neurocognitive dysfunction and anxiety-like behaviors. (2023, BMC Med, PMID:36600274)”, “score”: 0.436, “reason”: “14 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062128-afe67892”, “quality_score”: 0.74, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-16-gap-pubmed-20260411-082446-2c1c9e2d”, “title”: “The abstract explicitly questions whether AD’s hallmark pathologies induce cholinergic dysfunction or vice versa. This fundamental causality question is critical for determining therapeutic targets but remains unresolved despite evidence that β-amyloid affects cholinergic receptors.\n\nGap type: open_question\nSource paper: The cholinergic system in aging and neuronal degeneration. (2011, Behavioural brain research, PMID:21145918)”, “score”: 0.414, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-16-gap-pubmed-20260411-082446-2c1c9e2d”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}